Reveals conservative treatments for central retinal artery occlusion are futile and potentially harmful, highlighting the need for clinical trials of early systemic fibrinolytic therapy.
Our analysis suggests that a clinical trial of early systemic fibrinolytic therapy for CRAO is warranted and that conservative treatments are futile and may be harmful.
No takes yet. Share an insight, caveat, or question.
Schrag et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: